Telepoint SARS-CoV-2 IgM/IgM Rapid Test.kit is EUA authorized by the FDA.
The Telepoint SARS-CoV-2 IgG/IgM Rapid Test kit is a qualitative test for the detection and differentiation of IgG and IgM antibodies against SARS-CoV-2 in human serum, plasma (potassium EDTA), and potassium EDTA venous whole blood. The product is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
More Details: Testkit Details
PDF Insert: Detailed Insert
Download EUA and FDA Approval